---
schema_version: "secwatch.filing_event.v1"
accession: "0001867096-22-000070"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2022-06-08T23:59:59+00:00"
generated_at: "2026-06-25T03:40:30.933365+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Xeris Biopharma stockholders elect three Class I directors and ratify KPMG as auditor

## Summary
- Proposal 1: All three Class I director nominees elected: Bormann (41.5M for), Kong (46.4M for), Schmid (41.5M for).
- Proposal 2: Ratification of KPMG LLP as auditor for FY 2022 passed with 79.0M for, 687K against, 110K abstain.
- Broker non-votes totaled 32.1M shares on director elections.
- Annual meeting held June 8, 2022; 135.5M shares outstanding and entitled to vote.

## SEC filing metadata
- accession: 0001867096-22-000070
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2022-06-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000186709622000070/0001867096-22-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000186709622000070/xers-20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001867096-22-000070
- JSON: https://secwatch.observer/filing/0001867096-22-000070.json
- Plain text: https://secwatch.observer/filing/0001867096-22-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.